Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (20002)	3/23/1999 2:04:00 PM
From: Zebra 365	Read Replies (2) \| Respond to of 23519

<<However, it should be noted that the recent VVUS move was not a result of either Viagra or MUSE news but based on future R&D potential. BigKNY3>> Very true, but that is what Small Pharma is all about. That is why both you and I are holders of ICOS. Looks like your "slumming" paid off so far there. I know it has been a 100% return for me so far. Now if the shorts could just push VVUS down to 3 one more time, I'll have a good round number of shares. I really don't think there will be much long selling at this point unless there is some institutional window dressing at the end of this month. I have learned one thing about Small Pharma companies, that top managment is as important as product in the long run. Now BigK, you can say you told us so, and VLAD, BigK has been right on that point all along, you have to give him that. The more the sales of MUSE are in the hands of pros, the better off this company will be. Zebra